Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on September 24, 2026.

Follow

2.64% of the capital sold short
4 disclosing funds
434 disclosures on record
SE0002148817 ISIN code

Evolution of the disclosed total

Open positions

In the United States HNSBF (OTC): 25,732 shares sold short on September 15, 2026. FINRA names no fund.

On the other side: the funds that hold Hansa Biopharma AB Titelia

History of disclosures

Download 434 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

• Samhällsbyggnadsbolaget i Norden AB 12.10% of the capital sold short
• Elekta AB (publ) 9.31% of the capital sold short
• JM AB 7.21% of the capital sold short
• Bonesupport Holding AB 6.91% of the capital sold short
• Truecaller AB 6.88% of the capital sold short
• Hemnet Group AB (publ) 5.63% of the capital sold short
• Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
• Dynavox Group AB 5.38% of the capital sold short
• RaySearch Laboratories AB (publ) 4.96% of the capital sold short
• Aktiebolaget Electrolux 4.41% of the capital sold short
• AAK AB (publ) 4.31% of the capital sold short
• Hexatronic Group AB 3.77% of the capital sold short